Living With Fibrosis

Our
Patients

↓

We Are Here For Hope

Here at Pliant, the world’s top experts in fibrosis biology are hard at work with experienced drug developers to find safe and effective therapies for people with idiopathic pulmonary fibrosis (IPF), primary sclerosing cholangitis (PSC), and other fibrotic diseases.

 

Bernard Coulie talks about Pliant’s commitment to working with the Pulmonary Fibrosis Foundation (PFF) and advancing therapies for people living with debilitating fibrotic diseases.

Clinical Trials for Idiopathic
Pulmonary Fibrosis (IPF)

We are currently enrolling patients with idiopathic pulmonary fibrosis (IPF) in Phase 2 clinical trials for our lead investigational medicine, PLN-74809.

IPF Clinical Trial →

Clinical Trials for Primary
Sclerosing Cholangitis (PSC)

We are currently enrolling patients with primary sclerosing cholangitis (PSC) in Phase 2a clinical trials for our lead investigational medicine, PLN-74809.

PSC Clinical Trial →
Patient Resources
What to expect in the INTEGRIS-IPF clinical trial
Learn More →
What to expect in the INTEGRIS-PSC clinical trial
Learn More →
Clinical Trial FAQs
Learn More →

Organizations

Community

Find support and more information about fibrotic disease and how to participate in clinical trials from the following organizations.

PSCrevised copy
Pulmonary Fibrosis Foundation
American Liver Foundation (1)
Ciscrp
Crohns_Colitis
Global Fibrosis Foundation
MDA
NIH
Nord